Leading CROs and CDMOs turn to mass photometry for rapid protein, mRNA and viral vector analytics
Upstream AAV characterization powered by mass photometry
Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies
Refeyn Ltd recognized as a Top Employer for 2026 in the UK
Eight ways mass photometry is accelerating biological discovery
Refeyn announces appointment of Non-Executive Director
Refeyn welcomes Natalia Markova to Scientific Advisory Board
How mass photometry saves time (and money) in cryo-EM experiments (2025)
Transforming adenovirus (AdV) vector analysis with macro mass photometry
Mass photometry: The perfect team player for antibody analytics